HIV

Growing HIV incidence in young individuals could cause epidemic to become worse.

Targeting CD4+ T lymphocytes could help antiretroviral therapy eliminate all HIV.

New initiative supports several research collaborations to find a cure for HIV/AIDS.

Study sheds light on HIV development.

Care coordination with case management now found to improve HIV viral suppression in hospitalized patients.

Is the cost of specialty drugs worth the price in small patient populations?

Maternal antiretroviral therapy decreases the threat of HIV transmission through breast milk.

Interaction between HIV and the immune system are crucial to eradicating the disease.

CDC finds need for interventions to improve HIV testing rates among men between 15- and 39-years-old.

Efavirenz may aid in the breakdown and removal of cholesterol from the brain in Alzheimer’s disease patients.

New analysis may lead to the development of new antiviral HIV drugs.

Frequent CD4 cell monitoring is unnecessary in well-controlled HIV-positive patients, new study results suggest.

Tenofovir disoproxil fumarate and emtricitabine administered via a sustained release intravaginal ring shows promise treating (S)HIV.

Top news from across the health care landscape.

Four major hepatitis genotypes kill more people than HIV, malaria, and tuberculosis.

Syndros treats anorexia related to AIDS and cancer patients experiencing nausea and vomiting due to chemotherapy.

Syndros can be used to treat anorexia due to AIDS, and nausea and vomiting due to chemotherapy.

The FDA has approved Insys Therapeutics Inc's oral solution, Syndros, which is a liquid formulation of the pharmaceutical cannabinoid dronabinol.

Antiretroviral therapy may alleviate some cognitive problems among HIV-positive patients.

List prices for Complera and Stribild continue to rise for HIV treatment.

Off-label rilpivirine in combination with emtricitabine and tenofovir may help reduce out-of-pocket spending for patients with HIV.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

Targeting TEFb pathway may help improve treatment of uveitis.

Concern persists among physicians who treat HIV-associated lymphoma with stem cell transplants due to the risk of harming the immune system.